CROs/Service Providers

Accelsiors expands global footprint

Tuesday, January 24, 2017

Accelsiors has announced the opening of a new office in Gurgaon, India. This investment will provide our biotechnology, pharmaceutical and medical device customers with greater access to patient populations in an increasingly well-regulated environment.

[Read More]

WuXi AppTec acquires HD Biosciences

Friday, January 20, 2017

WuXi AppTec, a global pharmaceutical, biotechnology and medical device open-access capability and technology platform, has acquired HD Biosciences (HDB), a biology-focused preclinical drug discovery CRO. After completion of acquisition, HD Biosciences will become a wholly-owned subsidiary of WuXi, and will continue to focus on growing its core competences and providing greater services. The acquisition will further strengthen WuXi’s R&D capability from target validation to lead discovery and optimization, improving and expanding WuXi’s open-access enabling service platform.

[Read More]

CROS NT expands operations in India

Wednesday, January 18, 2017

CROS NT, a patient-centric and data-driven CRO, has announced the opening of its new office in Bangalore, India. The Bangalore office is the fourth global office established by CROS NT in the last six years, including branches in Italy, Germany, the U.K. and the U.S.

[Read More]

Parexel to restructure

Friday, January 13, 2017

Chairman, CEO and the Corporate Vice President and Interim CFO of Parexel International has approved a plan to restructure its operations to improve the productivity and efficiency of the company, simplify the organization and streamline decision-making, thereby enhancing client engagement. The restructuring initiative is company-wide.

[Read More]

LabCorp to acquire assets of Mount Sinai Clinical Outreach Laboratories

Wednesday, January 11, 2017

Laboratory Corporation of America Holdings (LabCorp), a life sciences company, and the Mount Sinai Health System, one of the largest health systems in metropolitan New York City, have entered into a definitive agreement for LabCorp to acquire assets of Mount Sinai’s Clinical Outreach Laboratories. When the transaction is complete, LabCorp will be available to provide comprehensive laboratory services to physicians and patients that currently use Mount Sinai’s outreach laboratory.

[Read More]

Helomics completes restructuring into fully-integrated CRO

Thursday, December 22, 2016

Helomics, a privately held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic and biotech industries, has announced the completion of the final phase of its corporate realignment toward becoming a fully-integrated clinical contract research and clinical products organization (ICCRO).  

[Read More]